Search

everythinglearnresearchcommunity

for

Search:↓

Lavender, lemongrass, rosemary, and chamomile essential oils may help protect cells important for hair growth from damage and could promote hair growth.

Low iron levels in the blood could be a sign of Telogen Effluvium, a type of hair loss, but it's not always accurate in distinguishing it from other hair loss types.

Losing both ERBB2 and ERBB3 receptors in mice causes significant skin problems and inflammation.

Exosomes from stem cells may help rejuvenate skin and regrow hair, but more research is needed.

Low HDL-C, uric acid, and 25-hydroxyvitamin D are risk factors for early-onset male hair loss.

Androgenetic alopecia in men is genetic and linked to health issues like obesity and heart disease, with treatments including minoxidil, finasteride, and hair transplants.

Light-based treatment, Photobiomodulation, shows promise for non-invasive skin therapy with few side effects.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

Arsenic exposure from contaminated water severely damages the skin, causing hair loss, pigmentation changes, irritation, and can lead to skin cancer.

Developing microRNA-based treatments is hard but has potential.

Large data can lead to new medical discoveries and personalized medicine.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Certain changes in the VEGF gene can increase or decrease the risk of polycystic ovary syndrome.

Optical imaging and light therapy show promise for diagnosing and treating liver injury caused by surgery.

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

ADSCs help in wound healing and skin regeneration but need more research for full understanding.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Taking too much vitamin E caused a young man's blood clotting problems, which improved after he stopped the vitamin E and got treatment.

High levels of TNF-α may contribute to obesity and insulin resistance in PCOS, but not due to the C850T genetic variation.

Charnoly bodies could be a marker for cell damage, and certain nutrients and proteins might prevent them, potentially helping with brain diseases and cancer.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

The MPV/PC ratio can help assess disease activity in alopecia areata.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Zinc acetate hydrate may help reduce fatigue and hair loss in post-COVID-19 patients.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Fibroblasts, cells usually linked to tissue repair, also help regenerate various organs and their ability decreases with age. Turning adult fibroblasts back to a younger state could be a new treatment approach.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.